169 related articles for article (PubMed ID: 34350062)
1. DGKζ exerts greater control than DGKα over CD8
Gu J; Wang C; Cao C; Huang J; Holzhauer S; Desilva H; Wesley EM; Evans DB; Benci J; Wichroski M; Wee S; Riese MJ
Oncoimmunology; 2021; 10(1):1941566. PubMed ID: 34350062
[TBL] [Abstract][Full Text] [Related]
2. The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling.
Joshi RP; Schmidt AM; Das J; Pytel D; Riese MJ; Lester M; Diehl JA; Behrens EM; Kambayashi T; Koretzky GA
Sci Signal; 2013 Nov; 6(303):ra102. PubMed ID: 24280043
[TBL] [Abstract][Full Text] [Related]
3. Diacylglycerol Kinase ζ Limits Cytokine-dependent Expansion of CD8
Andrada E; Liébana R; Merida I
EBioMedicine; 2017 May; 19():39-48. PubMed ID: 28438506
[TBL] [Abstract][Full Text] [Related]
4. Predominant contribution of DGKζ over DGKα in the control of PKC/PDK-1-regulated functions in T cells.
Ávila-Flores A; Arranz-Nicolás J; Andrada E; Soutar D; Mérida I
Immunol Cell Biol; 2017 Jul; 95(6):549-563. PubMed ID: 28163304
[TBL] [Abstract][Full Text] [Related]
5. Diacylglycerol kinase ζ controls diacylglycerol metabolism at the immunological synapse.
Gharbi SI; Rincón E; Avila-Flores A; Torres-Ayuso P; Almena M; Cobos MA; Albar JP; Mérida I
Mol Biol Cell; 2011 Nov; 22(22):4406-14. PubMed ID: 21937721
[TBL] [Abstract][Full Text] [Related]
6. Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals.
Arranz-Nicolás J; Ogando J; Soutar D; Arcos-Pérez R; Meraviglia-Crivelli D; Mañes S; Mérida I; Ávila-Flores A
Cancer Immunol Immunother; 2018 Jun; 67(6):965-980. PubMed ID: 29572701
[TBL] [Abstract][Full Text] [Related]
7. Diacylglycerol kinase ζ limits IL-2-dependent control of PD-1 expression in tumor-infiltrating T lymphocytes.
Arranz-Nicolás J; Martin-Salgado M; Rodríguez-Rodríguez C; Liébana R; Moreno-Ortiz MC; Leitner J; Steinberger P; Ávila-Flores A; Merida I
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33246984
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a enhances T cell activation by targeting diacylglycerol kinase ζ.
Shin J; Xie D; Zhong XP
PLoS One; 2013; 8(10):e77983. PubMed ID: 24147106
[TBL] [Abstract][Full Text] [Related]
9. Decreased diacylglycerol metabolism enhances ERK activation and augments CD8+ T cell functional responses.
Riese MJ; Grewal J; Das J; Zou T; Patil V; Chakraborty AK; Koretzky GA
J Biol Chem; 2011 Feb; 286(7):5254-65. PubMed ID: 21138839
[TBL] [Abstract][Full Text] [Related]
10. Combined inhibition/silencing of diacylglycerol kinase α and ζ simultaneously and synergistically enhances interleukin-2 production in T cells and induces cell death of melanoma cells.
Takao S; Akiyama R; Sakane F
J Cell Biochem; 2021 May; 122(5):494-506. PubMed ID: 33399248
[TBL] [Abstract][Full Text] [Related]
11. Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases.
Riese MJ; Wang LC; Moon EK; Joshi RP; Ranganathan A; June CH; Koretzky GA; Albelda SM
Cancer Res; 2013 Jun; 73(12):3566-77. PubMed ID: 23576561
[TBL] [Abstract][Full Text] [Related]
12. Negative control of diacylglycerol kinase ζ-mediated inhibition of T cell receptor signaling by nuclear sequestration in mice.
Xie D; Zhang S; Chen P; Deng W; Pan Y; Xie J; Wang J; Liao B; Sleasman JW; Zhong XP
Eur J Immunol; 2020 Nov; 50(11):1729-1745. PubMed ID: 32525220
[TBL] [Abstract][Full Text] [Related]
13. Diacylglycerol Kinase alpha in X Linked Lymphoproliferative Disease Type 1.
Velnati S; Centonze S; Girivetto F; Baldanzi G
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072296
[TBL] [Abstract][Full Text] [Related]
14. Diacylglycerol kinases in cancer.
Mérida I; Torres-Ayuso P; Ávila-Flores A; Arranz-Nicolás J; Andrada E; Tello-Lafoz M; Liébana R; Arcos R
Adv Biol Regul; 2017 Jan; 63():22-31. PubMed ID: 27697466
[TBL] [Abstract][Full Text] [Related]
15. The expression of diacylglycerol kinase isoforms α and ζ correlates with the progression of experimental autoimmune encephalomyelitis in rats.
Cui H; Huang Y; Wu Y; Ma J; Cao X; Xie J; Zhang Y
Histochem Cell Biol; 2021 Nov; 156(5):437-448. PubMed ID: 34312706
[TBL] [Abstract][Full Text] [Related]
16. Diacylglycerol Kinases (DGKs): Novel Targets for Improving T Cell Activity in Cancer.
Riese MJ; Moon EK; Johnson BD; Albelda SM
Front Cell Dev Biol; 2016; 4():108. PubMed ID: 27800476
[TBL] [Abstract][Full Text] [Related]
17. SAP-mediated inhibition of diacylglycerol kinase α regulates TCR-induced diacylglycerol signaling.
Baldanzi G; Pighini A; Bettio V; Rainero E; Traini S; Chianale F; Porporato PE; Filigheddu N; Mesturini R; Song S; Schweighoffer T; Patrussi L; Baldari CT; Zhong XP; van Blitterswijk WJ; Sinigaglia F; Nichols KE; Rubio I; Parolini O; Graziani A
J Immunol; 2011 Dec; 187(11):5941-51. PubMed ID: 22048771
[TBL] [Abstract][Full Text] [Related]
18. DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunity.
Wichroski M; Benci J; Liu SQ; Chupak L; Fang J; Cao C; Wang C; Onorato J; Qiu H; Shan Y; Banas D; Powles R; Locke G; Witt A; Stromko C; Qi H; Zheng X; Martin S; Ding M; Gentles R; Meanwell N; Velaparthi U; Olson R; Wee S; Tenney D; Parker CG; Cravatt BF; Lawrence M; Borzilleri R; Lees E
Sci Transl Med; 2023 Oct; 15(719):eadh1892. PubMed ID: 37878674
[TBL] [Abstract][Full Text] [Related]
19. Synergistic control of T cell development and tumor suppression by diacylglycerol kinase alpha and zeta.
Guo R; Wan CK; Carpenter JH; Mousallem T; Boustany RM; Kuan CT; Burks AW; Zhong XP
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11909-14. PubMed ID: 18689679
[TBL] [Abstract][Full Text] [Related]
20. Graded diacylglycerol kinases α and ζ activities ensure mucosal-associated invariant T-cell development in mice.
Pan Y; Deng W; Xie J; Zhang S; Wan ECK; Li L; Tao H; Hu Z; Chen Y; Ma L; Gao J; Zhong XP
Eur J Immunol; 2020 Feb; 50(2):192-204. PubMed ID: 31710099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
